Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenues:      
Royalties $ 59,423 $ 38,194 $ 29,994
Material sales 22,502 27,662 28,488
License fees, milestones and other revenues 27,048 6,058 6,056
Total revenues 108,973 71,914 64,538
Operating costs and expenses:      
Cost of sales [1] 5,571 5,807 9,136
Amortization of intangibles 10,643 2,375 2,375
Research and development 21,221 11,005 9,747
General and administrative 26,621 24,378 22,570
Lease exit and termination costs 1,032 1,020 1,084
Total operating costs and expenses 65,088 44,585 44,912
Income from operations 43,885 27,329 19,626
Other (expense) income:      
Interest expense, net (12,178) (11,802) (4,860)
Increase in contingent liabilities (3,334) (5,013) (5,135)
Gain on deconsolidation of Viking 0 28,190 0
Loss from Viking (23,132) (5,143) 0
Other income, net 2,719 1,768 1,671
Total other income (expense), net (35,925) 8,000 (8,324)
Income before income tax benefit (expense) 7,960 35,329 11,302
Income tax benefit (expense) (10,327) 192,115 (410)
Income (loss) from operations (2,367) 227,444 10,892
Discontinued operations:      
Gain on sale of Oncology Product Line before income taxes 1,139 0 0
Income tax expense on discontinued operations (408) 0 0
Income from discontinued operations 731 0 0
Net (loss) income including noncontrolling interests: (1,636) 227,444 10,892
Less: Net loss attributable to noncontrolling interests 0 (2,380) (1,132)
Net (loss) income $ (1,636) $ 229,824 $ 12,024
Basic per share amounts(1):      
Income (loss) from continuing operations (in usd per share) [2] $ (0.11) $ 11.61 $ 0.59
Income from discontinued operations (in usd per share) [2] 0.04 0.00 0.00
Net income (in usd per share) [2] $ (0.08) $ 11.61 $ 0.59
Weighted average shares outstanding (shares): 20,831 19,790 20,419
Diluted per share amounts(1):      
Income (loss) from continuing operations (in usd per share) [2] $ (0.11) $ 10.83 $ 0.56
Income from discontinued operations (in usd per share) [2] 0.04 0.00 0.00
Net (loss) income (in usd per share) [2] $ (0.08) $ 10.83 $ 0.56
Weighted average number of common shares-diluted (shares) 20,831 21,228 21,433
[1] Excludes amortization of intangibles
[2] The sum of net income per share amounts may not equal the total due to rounding